Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.7 (
sialyltransferase
)
1,534
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies indicate that sialylation of lipopolysaccharide (LPS) by host CMP-N-acetylneuraminic acid (CMP-NANA) catalyzed by bacterial
sialyltransferase
rendered gonococci resistant to killing by phagocytes, to entry into epithelial cell lines, to killing by immune serum and complement, and to absorption of complement component C3. These results have been confirmed by comparing a
sialyltransferase
-deficient mutant (strain JB1) with its parent (strain F62) in appropriate tests. In contrast to F62, JB1 was very susceptible to killing by human polymorphonuclear phagocytes in opsonophagocytosis tests and incubation with CMP-NANA did not decrease the level of killing. The inherent resistance of F62 in these tests was probably due to LPS sialylation by CMP-NANA and lactate present in the phagocytes. A JB1 variant expressing the invasion-associated Opa protein was as able to enter Chang human
conjunctiva
epithelial cells as an Opa-positive variant of F62, suggesting that the
sialyltransferase
is not required for Opa-mediated entry. After incubation with CMP-NANA, the number of F62 variant gonococci entering cells but not that of JB1 variant gonococci was drastically reduced. Both JB1 and F62 were killed by incubation with rabbit antibody to gonococcal major outer membrane protein, protein I, and human complement, but only F62 was rendered resistant to the killing by incubation with CMP-NANA. Finally, both JB1 and F62 absorbed similar amounts of complement component C3 and the binding was decreased by incubation with CMP-NANA only for the wild type, F62.
...
PMID:Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae. 875 78
The binding sites of the anti-cytosolic sialidase antibody and Maackia amurensis lectin II (MAL II: specific for sialic acid alpha 2, 3 galactose) in the epithelium of the rat cornea and
conjunctiva
were immunohistochemically and lectin-histochemically examined, respectively. Cytosolic sialidase was detected in the cytoplasm of the middle and basal epithelium of the cornea and
conjunctiva
, whereas MAL II bound to the apical region of their epithelium and the mucous of the goblet cells. The predominant action of the cytosolic sialidase, which is stronger than that of the
sialyltransferase
, may inhibit the terminal sialylation of the glycoconjugates at the middle and basal regions of the epithelium of the cornea and
conjunctiva
.
...
PMID:[Immunohistochemical localization of cytosolic sialidase in the epithelium of rat cornea and conjunctiva]. 931 Dec 29